The interaction between CD28 and its ligands, CD80 and CD86, is crucial for an optimal activation of antigen-specific T cells. However, the requirement of CD80 or CD86 co-stimulation in T h 2 cell differentiation and activation is controversial. Freshly isolated murine CD4 ⍣ and CD8 ⍣ T cells were incubated with P815 transfectants expressing a similar level of either CD80 or CD86 in the presence of anti-CD3 mAb. Both CD80 and CD86 co-stimulated the proliferation of CD4 ⍣ and CD8 ⍣ T cells at comparable time-kinetics and magnitude, but CD86 alone was able to co-stimulate IL-4 and especially IL-10 production in CD4 ⍣ T cells. In typical T h 2-dependent immune responses elicited by Nippostrongylus brasiliensis infection, the anti-CD86 mAb treatment but not the anti-CD80 mAb treatment efficiently inhibited antigen-specific IgE and IgG1 production, which was accompanied with the reduced IL-4 production. Our results suggest that CD86 co-stimulation plays a dominant role not only in the primary activation of T h 2 cells but also in the secondary interaction between antigen-primed T h 2 cells and B cells.
Introduction
Optimal activation of antigen-specific T cells requires engagethis co-stimulatory pathway results in the induction of antigen-specific unresponsiveness, or anergy, both in vitro ment of the TCR-CD3 complex and ligation of co-stimulatory receptor(s). The interaction of CD28 and its ligands CD80 and in vivo (3, 16, 17) . However, the requirements of CD28 signaling for differenti-(B7/BB1, B7-1) and CD86 (B70, B7-2) plays a central role in providing a co-stimulatory signal for primary T cell activation ation and activation of T h 2 cells, which secrete IL-4 and IL-10, stimulating B cells and enhancing IgG1 and IgE produc-(1-3). Both CD80 and CD86 have been shown to signal through CD28 and co-stimulate T cell proliferation, IL-2 protion, have been less well defined. IL-4 priming dominates over IL-12, directing naive CD4 ϩ T cells to differentiate duction and generation of cytotoxic T cells (4,5). However, CD80 and CD86 are differentially expressed on populations into T h 2 cells (18). Recent in vitro experiments suggest the preferential differentiation toward T h 2 cells by CD86 coof antigen-presenting cells (APC) and regulated by various cytokines and other factors (6-9). Most of the initial reports stimulation (19, 20) , although this issue is controversial and may depend on the particular experimental model (21, 22) . In demonstrating the importance of CD28 co-stimulation have been estimated in T h 1-dominant in vitro immune responses, mucosal immune responses to a nematode parasite, administration of a soluble chimeric CTLA-4 fusion protein (CTLA-4-such as T cell proliferation and IL-2 production (10-12). CD28 signal co-stimulates IL-2 production both by regulating gene Ig) inhibited the secretion of IL-4 and IgE (23) . Furthermore, treatment with CTLA-4-Ig within the first week of infection transcription and by stabilizing mRNA (13-15). Blockade of completely abrogated T h 2-mediated disease progression in Leishmania-susceptible BALB/c mice (24) . Similarly, Milich et al. (25) demonstrated that CTLA-4-Ig suppressed autoantibody production and elicited long-term unresponsiveness in an autoantigen-expressing transgenic mouse model. In addition, antibody responses to T-dependent antigen were profoundly inhibited in transgenic mice expressing a soluble form of CTLA-4 (26) . Antibody responses to viral antigen, but not cell-mediated delayed-type hypersensitivity reactions against lymphocytic choriomeningitis virus, were reduced in In contrast, it has been proposed that CD28 co-stimulation is less dependent on the activation of differentiated T h 2 cells (28, 29) . McKnight et al. (28) demonstrated that IL-4 secretion
In vitro co-stimulation assay by in vitro differentiated T h 2-like cells is not influenced by the Murine mastocytoma P815 cells transfected with either mouse co-stimulator-deficient APC. Webb et al. (29) demonstrated CD80 or CD86 cDNA (CD80-P815 or CD86-P815) were that CD28 co-stimulation is critical for the development of T h 0 prepared as described previously (32) . Isolated splenic CD4 ϩ and T h 2 subsets, but not for the maintenance of T h 2 cytokine or CD8 ϩ T cells were co-cultured with mitomycin C-treated production. Several recent in vivo studies suggest that block-P815, CD80-P815 or CD86-P815 cells in the presence or ade of CD28-B7 by CTLA-4-Ig inhibits T h 1 cytokines but absence of anti-CD3 mAb (2C11, 2 µg/ml) at indicated spares T h 2 cytokines (30, 31) . However, their experimental responder/stimulator (R/S) ratios in 96-well or 24-well flatmodels used in these studies were all T h 1-dominant immune bottomed microplates. RPMI 1640 supplemented with 10% responses. The distinct role of CD80 and CD86 co-stimulatory heat-inactivated fetal bovine serum, 2 mM glutamine, 1 mM molecules in the ongoing T h 2 immune responses has not sodium pyruvate, 0.05 mM 2-mercaptoethanol and antibiotics been well defined.
was used for culturing cells. For proliferative responses, Here we show a pivotal role of the CD86 co-stimulatory cultures were pulsed with [ 3 H]thymidine (0.5 µCi/well; DuPontmolecule for IL-4 production in T h 2-mediated immune NEN, Boston, MA) for the last 6 h and harvested after 72 h responses elicited by Nippostrongylus brasiliensis (Nb) on a Micro 96 Harvester (Skatron, Lier, Norway). Incorporated infection.
radioactivity was measured on a microplate β counter (Micro Beta Plus, Wallac, Turku, Finland). For assessment of cytokine production, culture supernatants were collected after the Methods indicated period of incubation and stored at -80°C until the assay. Mice Parasite infection and in vivo treatment BALB/c mice were purchased from Shizuoka Laboratory Animal Center (Shizuoka, Japan) and were used at 8-12
Groups of four to six BALB/c mice were injected s.c. with weeks of age.
750 third-stage larvae of Nb. Extracted Nb antigen and dinitrophenylated (DNP)-Nb antigen (DNP-Nb) were obtained as previously described (33) . After the initial infection, DNPmAb and specific reagent Nb (10 µg) was injected i.p. with 2 mg of Alum on day 14, Anti-CD80 (RM80) and anti-CD86 (PO3) were obtained and 35 and 49. For the in vivo treatment with mAb against CD80 purified as previously described (32) . Hybridomas producing and/or CD86, 250 µg/mouse of anti-CD80 (RM80), anti-CD86 mAb against MHC class II (M5/114), CD24 (J11d), CD3 (PO3) mAb or both in 0.5 ml PBS was administrated i.p. on (2C11), CD4 (RL172), CD8 (3.155) and Thy-1.2 (J1j) were day 14 and 16. As controls, either PBS or irrelevant rat IgG obtained from the ATCC (Rockville, MD).
(Sigma, St Louis, MO) was administrated. Serum samples were obtained on day 21, 35, 42 and 56 before the injection Cell separation of DNP-Nb and measured for IgG1, IgE and IgG2a anti-DNP T cells from spleen and mesenteric lymph nodes (MLN) were antibodies. The experimental schedule described above is purified as described previously (32) . For isolation of CD4 ϩ summarized in Fig. 1 . and CD8 ϩ T cells, purified T cells were treated with either Quantitation of serum anti-DNP IgG1, IgG2a and IgE anti-CD8 or anti-CD4 mAb and rabbit complement. CD4 ϩ and CD8 ϩ T cell fractions were always Ͼ95% CD4 ϩ and 90% DNP-specific IgE were detected by using the passive cutane-CD8 ϩ cells respectively, and they contained no detectable Ious anaphylaxis (PCA) reaction (33, 34) . For each serum, 0.1 A ϩ cells. Splenic B cells were purified by treatment with a ml aliquots of serial dilutions were injected intradermally into mixture of anti-Thy-1.2, anti-CD4 and anti-CD8 mAb and rabbit normal Wistar rats. The rats were challenged i.v. with 1 mg of complement. Purity was Ͼ90% B220 ϩ cells, as determined by DNP-BSA in 1 ml of 0.5% Evans blue 24 h after the intradermal injections. The reaction was examined 30 min after challenge. flow cytometry.
Titer was expressed as the highest dilution eliciting a reaction. DNP-specific IgG1 and IgG2a were measured by isotypespecific ELISA. DNP-BSA (10 µg/ml) solution was coated on ELISA plates (Immuron 2; Dynatech, Chantilly, VA). After blocking with 1% BSA in PBS, 50 µl of diluted serum samples were added and incubated for 60 min at room temperature. Plates were then washed and incubated with 50 µl horseradish peroxidase-conjugated horse anti-mouse IgG1 or rabbit antimouse IgG2a (Zymed, San Francisco, CA). After washing, plates were developed with H 2 O 2 and 2,2Ј-azino-bis-[3-ethylbenzthiazolin-6-sulfonic acid]. The absorbance at 415 nm was measured on an automated spectrometer (Bio-Rad, from Nb-infected mice. Cytokine concentrations in culture supernatants were determined after 48 and 72 h culture. Cells were also cultured at a concentration of 5ϫ10 5 /well in 96-well flat-bottomed microplates. Nb antigen (50 µg/ml) and either CD86 using a similar assay system. Purified CD4 ϩ and CD8 ϩ irradiated splenocytes or purified B cells (5ϫ10 5 cell/well) as T cell fractions isolated from BALB/c splenocytes were co-APC were added and proliferative response was evaluated, cultured with either mCD80-P815, mCD86-P815 or parental as described above.
P815 cells in the presence of a suboptimal dose of anti-CD3 Quantification of cytokines mAb. We measured the proliferative responses 3 days after culture, since maximal responses were observed on day 3 in Cell-free culture supernatants were assayed by cytokineboth CD4 ϩ and CD8 ϩ T cells from the time-kinetics study specific ELISA for IL-2, IL-4, IFN-γ and IL-10 according to the (data not shown). As shown in Fig. 2 , various numbers of protocol recommended by the manufacturer. All anti-mouse P815 cells transfected with either CD80 or CD86 provided cytokine mAb and cytokine standards were obtained from equivalent and efficient co-stimulation to CD4 ϩ T cell proliferaPharMingen (San Jose, CA). The following combinations of tion. CD8 ϩ T cells were also co-stimulated similarly by either captured and biotinylated mAb were used respectively: JES6-CD80 or CD86, although the levels of proliferative responses 1A12 and JES6-5H4 (anti-IL-2), BVD-1D11 and BVD6-24G2
were clearly lower than that of CD4 ϩ T cells. However, none (anti-IL-4), R46A2 and XMC1.2 (anti-IFN-γ), and JESS-2A5 of the T cells co-stimulated by parental P815 cells responded and SXC1 (anti-IL-10). All cytokine levels were calculated in this condition. In proliferative responses, murine CD80 and using standard curves with known amounts of recombinant CD86 seem to have comparable co-stimulatory abilities in cytokines.
both CD4 ϩ and CD8 ϩ T cells.
Statistical analysis
Preferential production of IL-4 and IL-10 by CD4 ϩ T cells Mann-Whitney rank-sum test was performed to determine the co-stimulated by CD86 statistical significance. P Ͻ 0.05 was considered significant.
We next determined the cytokine secretion in the supernatants after 48 and 72 h culture. As shown in Fig. 3 , both freshly Results isolated CD4 ϩ and CD8 ϩ T cells secreted a similar level of IL-2 and IFN-γ in response to CD80 and CD86 co-stimulation, Both CD80 and CD86 equivalently co-stimulate proliferation although the levels of IL-2 production from CD4 ϩ T cells and of CD4 ϩ and CD8 ϩ T cells IFN-γ production from CD8 ϩ T cells were clearly higher. A notable difference was observed in IL-4 and IL-10 production To compare the co-stimulatory ability of murine CD80 and CD86 for proliferative responses and cytokine productions, from CD4 ϩ T cells. CD4 ϩ T cells produced high levels of IL-4 and IL-10 when co-stimulated by CD86. In contrast, cowe generated murine mastocytoma P815 transfectants expressing either murine CD80 or CD86 at equivalent levels stimulation with CD80 could not induce detectable levels of IL-4 and IL-10 after 48 h stimulation and induced significantly determined by the binding to mouse CTLA-4-Ig (32) . Previously, we reported that murine P815 cells transfected with lower levels of IL-4 even after 72 h stimulation. In addition, CD8 ϩ T cells did not secrete significant levels of IL-4 and either human CD80 or CD86 have similar co-stimulatory abilities for T cell proliferation, cytokine production and the IL-10. No detectable cytokines were observed in cultures stimulated with anti-CD3 mAb and parental P815 cells (data generation of CTL in the presence of anti-CD3 mAb (5). We now compared co-stimulatory abilities of mouse CD80 and not shown). Titration of anti-CD3 mAb from 10 to 0.2 µg/ml yielded similar results (data not shown). These findings sug-DNP IgE and IgG1 production. It seems unlikely that the smaller effect of the anti-CD80 mAb was due to the lower gest that co-stimulation with CD86, but not CD80, stimulates murine CD4 ϩ T cells to produce T h 2-type cytokines, IL-4 and binding affinity to CD80 or the lower binding ability of the mAb used in this study, since we demonstrated that both IL-10.
anti-CD80 mAb (RM80) and anti-CD86 mAb (PO3) had similar In vivo treatment with anti-CD86 mAb efficiently inhibits blocking ability in a dose-dependent blocking assay in vitro antigen-specific IgE and IgG1 production elicited by Nb previously (32) . None of these treatments affected anti-DNP infection IgG2a production. As shown in Table 1 , the levels of IgE and IgG1 antibody production in control mice were gradually Infection with the helminthic parasite Nb induces preferential activation of T h 2 cells, which can provide cognate help for B increased by further repeated injection of DNP-Nb. The inhibitory effect for IgE and IgG1 by the initial treatment with cells, and results in selective IgE and IgG1 secretion, for which IL-4 is a critical cytokine (35). To determine the in vivo anti-CD86 mAb alone became minimal on day 42, whereas the treatment with anti-CD86 mAb, together with anti-CD80 requirements of co-stimulation in antigen-primed T h 2 cell activation, we investigated the effect of anti-CD80 and/or antimAb, sustained a significant suppressive effect on day 42. These results suggest that both CD80 and CD86 co-stimulate CD86 mAb treatment on the secondary antibody responses against Nb antigen. BALB/c mice were infected with Nb and T h 2 cells to provide help for B cells in producing antigenspecific IgE and IgG1, but CD86 is predominant. then DNP-conjugated Nb antigen (DNP-Nb) was injected i.p. (Fig. 1) . Anti-CD80, anti-CD86 or both mAb were administrated IL-4 production by MLN cells is inhibited by the in vivo i.p. 2 h before and 2 days after the secondary immunization treatment with anti-CD86 mAb alone or a combination of (on days 14 and 16). Serum samples were taken for measureboth mAb ment of DNP-specific IgG1, IgG2a and IgE. Figure 4 shows representative data at 3 weeks after the secondary antigen IL-4 produced by Nb antigen-primed T cells plays a critical role in hyperproduction of IgE and IgG1 in Nb-infected stimulation (on day 35). During 1-3 weeks after secondary immunization, the anti-CD86 mAb treatment alone significantly mice (36, 37). We, therefore, investigated IL-4 production by T cells from mAb-treated mice. MLN cells from mice suppressed DNP-specific IgE and IgG1 production. In contrast, the anti-CD80 mAb treatment did not affect their productreated with anti-CD80, anti-CD86 or both mAb were cocultured with soluble Nb antigen for 72 h, and the production tion. However, the addition of anti-CD80 mAb further augmented the suppressive effect of anti-CD86 mAb on antifor IL-4 and IFN-γ in the supernatant was measured. As shown in Fig. 5(A) , the treatment with anti-CD86 mAb significantly suppressed IL-4 secretion, as compared with control mice. Additional suppression in cytokine production was observed by a combination of both mAb. IFN-γ production was not augmented by Nb antigen stimulation and was not affected by mAb treatments. To define whether the function of T cells or APC was affected by in vivo treatment with anti-CD86, MLN T cells from anti-CD86-treated mice were cultured with either anti-CD86-treated or untreated splenic B cells. Nb-primed T cells from the anti-CD86 mAb-treated mice produced a high level of IL-4 in the presence of untreated primed B cells, whereas B cells treated with anti-CD86 mAb failed to induce IL-4 production in the same T cell fraction, suggesting that APC function of B cells was affected by the treatment with anti-CD86 mAb (Fig. 5B) . Consistent with prior reports in in vitro activated splenic B cells, CD86 was preferentially expressed on Nb-infected splenic B cells compared with CD80. This result also indicated the dominant contribution of CD86 in the T-B cognate interaction. However, since we confirmed that CD86 expression on B cells was not affected by the anti-CD86 mAb treatment, it is unlikely that the lower APC against recall antigen, we evaluated proliferative responses of MLN T cells stimulated with Nb antigen presented by production. Both CD4 ϩ and CD8 ϩ T cell subsets proliferated equally when co-stimulated by CD80 and CD86. However, either unprimed or Nb-primed B cells. Splenic B cells from Nb-infected mice efficiently stimulated the proliferation of the magnitude of the proliferative response was lower in CD8 ϩ T cells than in CD4 ϩ T cells. The difference observed Nb-primed MLN T cells in the presence of Nb antigen, while B cells from uninfected mice could not (Fig. 6A) . In between CD4 ϩ and CD8 ϩ T cells may result from their differential cytokine production. CD4 ϩ T cells produced contrast, MLN T cells from uninfected mice did not proliferate well even in the presence of Nb-primed B cells (data not more IL-2 than CD8 ϩ T cells, while CD8 ϩ T cells produced more IFN-γ than CD4 ϩ T cells. Since IFN-γ does not directly shown). This suggested that the proliferative response was caused by a cognate interaction between Nb-primed B stimulate proliferation of T cells, the proliferative ability may reflect the amount of secreted IL-2 from these T cell cells and Nb-primed T cells. We next examined the inhibitory effects of anti-CD80 and/or anti-CD86 mAb on this Nbsubsets. A notable finding in our present study was the prominent production of IL-10 from CD4 ϩ T cells cospecific T cell proliferative response using the Nb antigenprimed MLN T cells. As shown in Fig. 6(B) , the addition stimulated by CD86. We also observed a high IL-4 production by CD86 co-stimulation, in agreement with the of anti-CD86 mAb efficiently suppressed the Nb antigeninduced proliferation, while the addition of anti-CD80 mAb previous report by Freeman et al. (19) . By contrast, two groups (21, 22) demonstrated equivalent levels of cytokine showed only a minimal inhibitory effect. These results also suggest that CD86 is a dominant co-stimulator in antigenproduction, including IL-4, between CD80 and CD86 costimulation. This discrepancy could be due to the distinct specific cognate interaction between primed T h 2 and B cells.
parental cells used for transfection or the distinct responder T cell fractions used in their studies. In our previous report Discussion using P815 cells transfected with human CD80 or CD86, we only detected a minimal amount of IL-4 by the CD86 In this study, we examined the role of CD80 and CD86 co-stimulatory molecules in T h 2 activation and cytokine co-stimulation (5). This discrepancy might be dependent dominant immune response elicited by Nb infection. It has been generally accepted that the elevation of IgE in the Nb-infected mice is regulated by IL-4-producing T h 2 cells (35,37). Most previous reports evaluating the role of CD80 on the different expression levels of the transfected molecules or the genetic heterogeneity in humans. To and CD86 co-stimulation used T h 1-dependent in vivo experimental models (20, (41) (42) (43) . Therefore, the effect of examine the possibility that the presently observed T h 2-dominant cytokine production was due to the genetic CD80 or CD86 blockade with mAb in T h 2-mediated immune responses has not been properly examined. We here background of the BALB/c mice, known to secrete high levels of IL-4 (38), we have examined cytokine patterns in investigated the effect of anti-CD80 and/or anti-CD86 mAb treatment on the T h 2-mediated immune response. The fact C57BL/6 mice using the same experimental system. In contrast to BALB/c mice, marginal levels (55 Ϯ 15 pg/ml) that the IgE and IgG1 antibody production was efficiently inhibited by anti-CD86 mAb treatment alone suggests that of IL-4 production were observed in CD4 ϩ T cells from C57BL/6 mice induced by CD80 and CD86 co-stimulation.
T h 2 cell activation was mostly dependent upon CD86 costimulation (Fig. 4) . In addition, our observation that antigenHowever, IL-10 production in C57BL/6 mice after 72 h costimulation by CD86 was comparable to that from BALB/c specific IL-4 production was also inhibited by anti-CD86 treatment further supports the dominant role of CD86 comice (1365 Ϯ 445 pg/ml in C57BL/6 versus 1490 Ϯ 562 pg/ml in BALB/c), whereas no detectable IL-10 was observed stimulation to T h 2 cells (Fig. 5) . In contrast, the anti-CD86 mAb treatment did not affect IFN-γ or IgG2a production, when co-stimulated by CD80. Preferential production of IL-10 by CD86 co-stimulation may be a unique function of which is mostly dependent on T h 1 cell activation. This result suggests that the blockade of CD86 co-stimulation inhibited T h 2 cells. It has been demonstrated that IL-10 suppresses T h 1-development (39, 40) and IL-4 predominate over IL-12 T h 2 cell activation only and did not influence T h 1 cell activation. In contrast with our results, several reports or IFN-γ in dictating the differentiation of naive T cells to T h 2. Our results suggest that CD86 co-stimulation is showed that blocking of the CD28-B7 co-stimulatory pathway by CTLA-4-Ig efficiently inhibits T h 1 cytokines but not T h 2 capable of activating T h 2 cells and enhancing T h 2 cytokine production, while CD80 co-stimulation seems to be less cytokines (30, 31) . However the experimental models used in these studies were predominantly T h 1-dependent. In efficient in activating T h 2 cells.
We further examined the requirement of CD86 cogeneral, T h 1 cell activation and differentiation are under the influence of T h 2 cytokines, whereas already differentiated stimulation for T h 2 cell activation in vivo using a T h 2-MLN mesenteric lymph node T h 2 cells are less affected by T h 1 cytokines (44-46).
PCA passive cutaneous anaphylaxis
Therefore the inhibition of T h 1 cell activation by the blockade of co-stimulation could influence the activation state of T h 2 cells. References Several previous reports suggested that primed T cells are less dependent on CD28 co-stimulation than naive T
